2009
DOI: 10.1055/s-0029-1191789
|View full text |Cite
|
Sign up to set email alerts
|

Detection of Novel Biomarkers of Liver Cirrhosis by Proteomic Analysis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
43
0

Year Published

2010
2010
2020
2020

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 30 publications
(43 citation statements)
references
References 0 publications
0
43
0
Order By: Relevance
“…Transgelin expression has been shown to be upregulated in fibrotic areas of hepatic sections from patients with liver cirrhosis showing intense staining in broad cirrhotic septa. In contrast, in normal liver, transgelin is expressed in the wall of blood vessels, in portal areas, and in some fibroblasts in portal areas but not in epithelial cells and hepatocytes (23). Transgelin expression was also found to be upregulated in the lungs of patients with idiopathic pulmonary fibrosis, and its expression was localized to fibroblastic foci and smooth muscle (34).…”
Section: Discussionmentioning
confidence: 89%
“…Transgelin expression has been shown to be upregulated in fibrotic areas of hepatic sections from patients with liver cirrhosis showing intense staining in broad cirrhotic septa. In contrast, in normal liver, transgelin is expressed in the wall of blood vessels, in portal areas, and in some fibroblasts in portal areas but not in epithelial cells and hepatocytes (23). Transgelin expression was also found to be upregulated in the lungs of patients with idiopathic pulmonary fibrosis, and its expression was localized to fibroblastic foci and smooth muscle (34).…”
Section: Discussionmentioning
confidence: 89%
“…Serum tests [12][13][14][15] and various imaging methods such as ultrasound elastography or magnetic resonance (MR) spectroscopy, MR diffusion and MR elastography [16] have been investigated for staging and diagnosing liver disease. However, MR relaxometry appears to be a promising tool for analysing disease processes in other organ systems [17], and there is evidence that indicates its usefulness in detecting liver disease [18][19][20][21].…”
Section: Introductionmentioning
confidence: 99%
“…Recent studies evaluating two-dimensional gel electrophoresis coupled to mass spectrometry to differentiate fibrosis stages in CHC infection have identified new proteins of interest such as Mac-3-binding protein, hemopexin, fetuin-A, and Noninvasive tools to assess liver disease Patel 229 leucine-rich a-2 glycoprotein [29 ]. A tissue-based proteomics study [30] using microdissection of cirrhotic septa revealed microfibril-associated protein 4 as a candidate biomarker that predicts cirrhosis in CHC patients with a high degree of accuracy. Validation of these candidate proteins, along with issues regarding cost, reproducibility, and high-throughput capability, will need to be addressed in future studies.…”
Section: Genetic Markers Of Disease Progression and Proteomicsmentioning
confidence: 99%